Connexin 37 and cardiovascular events in a Madeiran cohort
Revista Portuguesa de Cardiologia · 2026-08 · 45 (8) · 431-432
DOI: 10.1016/j.repc.2026.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Portuguesa de Cardiologia, 2026-08. Verfasst von Rui Providência. Beteiligte Einrichtung: Cardiology Department, Hospital da Luz Arrábida, Vila Nova de Gaia, Portugal; Institute of Health Informatics Research, University College London, Lo…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute for Health and Care Research, Horizon Therapeutics, European Research Council.
Abstract (Originalsprache)
Cardiovascular disease remains the main cause of death in Portugal 1 , and risk stratification, with identification of individuals at risk, is still an unfinished challenge of contemporary medicine.The Gap Junction Alpha-4 (GJA4) gene and its encoded protein, connexin 37 (Cx37), were associated with adverse outcomes in the Framingham Heart Study 3 , and later in other cohorts 4 .Cx37 is a gap junction protein expressed in endothelial cells, macrophages, and platelets.It helps protect against atherosclerosis by preventing monocyte adhesion and regulating endothelial cell growth, controlling endothelial permeability, and limiting inappropriate blood clot formation by downregulating platelet reactivity 5 .The GJA4 rs618675 T >C single-nucleotide polymorphism has previously been identified as significantly associated with an increased risk of cardiovascular events.In this cohort of 1421 randomly selected adults from Madeira with no apparent cardiovascular disease, followed for an average of 7.3 ±6.0 years, Mendonc ¸a et al. report higher rates of cardiovascular events -including a composite of nonfatal myocardial infarction, unstable angina, percutaneous coronary intervention or coronary artery
Autor:innen und Institutionen
- Cardiology Department, Hospital da Luz Arrábida, Vila Nova de Gaia, Portugal; Institute of Health Informatics Research, University College London, London, UK; Barts Heart Centre, Barts Health NHS Trust, London. Electron…
Förderung
- National Institute for Health and Care Research
- Horizon Therapeutics
- European Research Council
- UK Research and Innovation
- Bupa Health Foundation
Zitieren
APA
Providência, R. (2026). Connexin 37 and cardiovascular events in a Madeiran cohort. Revista Portuguesa de Cardiologia, 45(8), 431-432. https://doi.org/10.1016/j.repc.2026.07.001
Vancouver
Providência R. Connexin 37 and cardiovascular events in a Madeiran cohort. Revista Portuguesa de Cardiologia. 2026;45(8):431-432. doi:10.1016/j.repc.2026.07.001
BibTeX
@article{Providncia2026,
author = {Providência, Rui},
title = {Connexin 37 and cardiovascular events in a Madeiran cohort},
journal = {Revista Portuguesa de Cardiologia},
year = {2026},
volume = {45},
number = {8},
pages = {431--432},
doi = {10.1016/j.repc.2026.07.001}
}
EUVIMED